MEDINA is a drug discovery organization and a partner site of the European research infrastructure EU-OPENSCREEN (www.eu-openscreen.eu). Leveraging our drug discovery expertise, the potential of our natural product libraries and the high throughput screening and...
MEDINA joins the global COVID-19 research effort looking for new therapeutics and diagnostic solutions for SARS-CoV-2.
First evidence of anticancer and antimicrobial activity in Mediterranean mesopelagic species.
New article by Fundacion MEDINA in collaboration with the Marine Biotechnology Department at the Stazione Zoologica Anton Dohrn, Naples, and the Department of Chemical, Biological, Pharmaceutical and Environmental Sciences (ChiBioFarAm) of the University of Messina:...
BSP meeting Trypanosomiasis & Leishmaniasis Symposium: Novel Advances in Basic and Applied Research. March 8 – 11, Granada- Spain.
Dr. Freddie Annang, a specialist in drug discovery against parasitic diseases from Fundación MEDINA, attended the BSP meeting entitled “Trypanosomiasis & Leishmaniasis Symposium: Novel Advances in Basic and Applied Research” which took place in Granada from the...
Visit MEDINA media library to view and download media resources, including documents, images and videos.
Subscribe to the latest news and updates from MEDINA on email, RSS and more.
Read in-depth news about how MEDINA is addressing drug discovery progress through recent headlines.